Dermal Fillers Market Worth $12.2 Billion By 2030 | CAGR: 8.7%

Dermal Fillers Market Growth & Trends

The global dermal fillers market size is anticipated to reach USD 12.2 billion by 2030, registering a CAGR of 8.7% over the forecast period, according to the new report of Grand View Research, Inc. Dermal fillers are soft tissue injectables that are injected into different depths of the skin and assist in treating signs of aging, loss of volume, facial contouring, etc. The ever-rising demand for aesthetic treatments that are safe and effective, increasing focus on appearance, rising disposable income, and growing geriatric population are expected to boost the market growth. As per the American Society of Plastic Surgeons, dermal fillers differ in chemical makeup and longevity and have varying degrees of softness.

For example, softer fillers are used on the lips, while sturdier fillers areused to enhance cheekbones. The ASPS reported that in 2020, around 2,619,650 hyaluronic acid dermal filler treatments were carried out in the U.S, and brands like Juvederm Ultra, Juvederm Ultra Plus, Perlane, Restylane, Belotero were the most preferred.The product demand is expected to increase significantly due to the fact that it provides desired results for individuals and can also be reversed if the patient is not satisfied with the results.

Growing social media influence, high consciousness about aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the factors driving the market growth.In light of COVID-19, the market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended during the first half of 2020. However, the demand has been on the rise post-pandemic. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to boost the market growth.

 Request a free sample copy or view report summary: Dermal Fillers Market Report

Dermal Fillers Market Report Highlights

• The hyaluronic acid dermal filler segment held the largest share and is expected to witness the highest growth rate during the forecast period

• The biodegradable type segment held the largest revenue share in 2022 as this is the most adopted filler-type product used by professionals and individuals

• The wrinkle correction application segment held the largest market share in 2022 due to an increasing focus on looking younger and treating signs of aging

• The MedSpa segment was the largest in 2022due to the fact that MedSpa provides aesthetic treatments under the supervision of a licensed medical practitioner

• North America dominated the market in 2022 due to the rising awareness about such procedures and the presence of skilled aesthetic professionals

Dermal Fillers Market Segmentation

Grand View Research has segmented the global dermal fillers market on the basis of product, type, application, end-use, and region:

Dermal Fillers Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hyaluronic Acid

• Calcium Hydroxylapatite

• Polylactic Acid (PLLA)

• Polymethyl-methacrylate Microspheres

• Others

Dermal Fillers Type Outlook (Revenue, USD Million, 2018 - 2030)

• Biodegradable

• Non-biodegradable

Dermal Fillers Application (Revenue, USD Million, 2018 - 2030)

• Wrinkle Correction

• Facial Contouring

• Scar Treatment

• Lip Enhancement

• Others

Dermal Fillers End-use Outlook (Revenue, USD Million, 2018 - 2030)

• MedSpa

• Cosmetic Surgery Clinics

• Hospitals

Dermal Fillers Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Mexico

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Dermal Fillers Market

• Merz Pharma

• Suneva Medical, Inc.

• Medytox Inc.

• Sinclair Pharma

• Prollenium Medical Technologies

• Galderma

• Allergan, Inc.

• Revance Therapeutics Inc.

• Bioplus Co. Ltd

• Bioaxis Pharmaceuticals

• Teoxane Laboratories

• Huadong Medicine Co., Ltd.

• Marllor Biomedical SRL